Dexcom Continuous Glucose-Monitoring System Nabs FDA Breakthrough Device Designation
Dexcom has been granted FDA Breakthrough Device Designation of its new continuous glucose monitoring system for use in the hospital setting.
Read MoreMar 2, 2022 | FDA Updates, Remote Monitoring | 0 |
Dexcom has been granted FDA Breakthrough Device Designation of its new continuous glucose monitoring system for use in the hospital setting.
Read MoreFeb 7, 2022 | Service Solutions | 0 |
The future of service encompasses new technologies that change the way manufacturers communicate, share data, educate, and provide valuable in-person or remote service to their customers. Here are some examples.
Read MoreJan 28, 2022 | Patient Care Equipment | 0 |
Insulet received clearance from the FDA for its Omnipod 5 Automated Insulin Delivery System for individuals with type 1 diabetes.
Read MoreJan 14, 2022 | Contracts, Ultrasound | 0 |
ZetrOZ Systems signed an agreement to provide U.S. government healthcare institutes with its sustained acoustic medicine (SAM) device.
Read MoreJan 4, 2022 | Company News, FDA Updates | 0 |
Zynex—a medical device company—has submitted a 510(k) application to the FDA for its fluid monitoring system.
Read More